ImmunoPrecise Antibodies Ltd. (IPA)
NASDAQ: IPA · IEX Real-Time Price · USD
1.260
0.00 (0.00%)
At close: May 1, 2024, 3:52 PM
1.220
-0.040 (-3.17%)
After-hours: May 1, 2024, 4:52 PM EDT
ImmunoPrecise Antibodies Market Cap
ImmunoPrecise Antibodies has a market cap or net worth of $32.89 million as of May 1, 2024. Its market cap has decreased by -56.66% in one year.
Market Cap
32.89M
Enterprise Value
38.78M
1-Year Change
-56.66%
Ranking
Category
Stock Price
$1.26
Market Cap Chart
Since December 31, 2020, ImmunoPrecise Antibodies's market cap has decreased from $250.60M to $32.89M, a decrease of -86.87%. That is a compound annual growth rate of -45.64%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 30, 2024 | 33.70M | -6.65% |
Apr 29, 2024 | 36.10M | 4.03% |
Apr 26, 2024 | 34.70M | 10.51% |
Apr 25, 2024 | 31.40M | -2.18% |
Apr 24, 2024 | 32.10M | - |
Apr 23, 2024 | 32.10M | -2.43% |
Apr 22, 2024 | 32.90M | -0.90% |
Apr 19, 2024 | 33.20M | 1.84% |
Apr 18, 2024 | 32.60M | -2.40% |
Apr 17, 2024 | 33.40M | -1.47% |
Apr 16, 2024 | 33.90M | 3.99% |
Apr 15, 2024 | 32.60M | -8.94% |
Apr 12, 2024 | 35.80M | -0.83% |
Apr 11, 2024 | 36.10M | -1.37% |
Apr 10, 2024 | 36.60M | 0.83% |
Apr 9, 2024 | 36.30M | -2.94% |
Apr 8, 2024 | 37.40M | -1.32% |
Apr 5, 2024 | 37.90M | -0.79% |
Apr 4, 2024 | 38.20M | - |
Apr 3, 2024 | 38.20M | -1.29% |
Apr 2, 2024 | 38.70M | -3.97% |
Apr 1, 2024 | 40.30M | 0.75% |
Mar 28, 2024 | 40.00M | -3.15% |
Mar 27, 2024 | 41.30M | 3.25% |
Mar 26, 2024 | 40.00M | - |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Brainstorm Cell Therapeutics | 36.88M |
Marker Therapeutics | 36.64M |
Co-Diagnostics | 36.57M |
Eyenovia | 36.29M |
Lucid Diagnostics | 36.22M |
Protara Therapeutics | 35.44M |
BriaCell Therapeutics | 34.52M |
Acurx Pharmaceuticals | 34.51M |